63 results about "Blood test" patented technology

The invention discloses a bone defect repair material suitability prediction method based on deep learning, and the method comprises the steps: carrying out the overlapping and uniform partitioning of a bone defect region and a host bone region in three-dimensional CT image data, carrying out the position coding and feature extraction of a plurality of sub-blocks through a three-dimensional visual Transform model of multi-scale position coding, and obtaining the anatomical and functional features; calculating a bone metabolism activity score and a systemic inflammation score based on blood detection data, and then constructing pathophysiological features; performing multi-round interaction on the anatomical and functional features, the pathophysiological features, the parameter data and the multidirectional multi-head cross attention layer, in each round, selecting one modal feature as a query vector, and selecting any modal feature in the rest modal features as a key vector and a value vector; and fusing the interaction features of each round, and determining the suitability score and the risk level of the bone repair material by combining the attention weight and the bone metabolism activity score in the multidirectional multi-head cross attention layer.

The utility model belongs to the technical field of blood detection sampling devices, and particularly relates to a blood detection sampling collector which comprises a main body and two first clamping grooves, a first connecting sleeve and a second connecting sleeve are inserted into the two first clamping grooves respectively, first clamping blocks are clamped with the interiors of the first clamping grooves, and second clamping blocks are clamped with the interiors of the second clamping grooves respectively. Limiting sleeves are clamped in the two limiting frames, rectangular grooves are formed in the bottoms of the two limiting frames, compression springs are fixedly connected to the inner tops of the limiting grooves, movable semi-rings are fixedly connected to the bottoms of the compression springs, fixing rings are fixedly connected to the inner side walls of the limiting sleeves, and diaphragms are fixedly connected to the interiors of the fixing rings. By arranging the limiting frame, the compression spring, the movable semi-ring, the limiting sleeve and the diaphragm, air isolation of a needle output hole is achieved, and pollution to blood in the main body caused by long-term exposure of the needle is avoided; and by arranging a first stop block and a second stop block, the two limiting frames can be conveniently limited by the limiting block.

This application provides a diabetes assessment device and a diabetes assessment method, relating to the field of image processing technology. The diabetes assessment device includes: an image determination module configured to determine a fundus image to be assessed, wherein the fundus image is used to characterize the physiological structures of the fundus; and a diabetes assessment module configured to determine a diabetes assessment result based on the fundus image to be assessed. By setting the image determination module, the fundus image to be assessed can be determined; by setting the diabetes assessment module, the diabetes assessment result can be determined based on the fundus image to be assessed. That is, invasive examinations such as blood tests are unnecessary; the diabetes assessment result can be determined solely based on the fundus image to be assessed, without causing harm to the patient's physical or mental health.

Provided are a resistive random-access memory (RRAM)-based blood test system and method. The system comprises: a computing chip, an RRAM chip, a power supply module, and a sensor module; the computing chip is connected to the RRAM chip; the RRAM chip is connected to the sensor module; and the power supply module is connected to the computing chip and the RRAM chip; the sensor module is configured to test a substance in blood and convert test result data into a plurality of pieces of first voltage data; the RRAM chip is configured to preprocess the received plurality of pieces of first voltage data and obtain second current data; and the computing chip is configured to, based on the second current data, perform a function computation on the second current data according to a preset function computation model, and obtain a blood-based classification result.

Eating only one meal a day can slow down the brain's awakening and onset of activity in the morning after sleep. [Solution] A transparent diet, in which the blood test data values ​​of the food consumed are known, is eaten in the morning or at noon, and a free meal is eaten in the evening. The contents of the free meal are then compared with the blood test data, and the diet is adjusted accordingly.

The blood test tube support convenient to place comprises a support body, the support body is fixedly connected with a base, a lifting block is arranged on the outer wall of the support body, a position adjusting mechanism is arranged between the lifting block and the support body, and lifting handles are rotationally connected to the outer walls of the two ends of the top of the support body. A plurality of protection pipes are arranged on the outer wall of the top of the lifting block, the inner walls of the protection pipes are hollow, movable plates are arranged on the inner walls of the protection pipes, and clamping limiting mechanisms are arranged between the movable plates and the protection pipes. According to the device, the test tubes can be sealed and stored through the multiple protection tubes arranged on the outer wall of the lifting block, the test tubes can enter the protection tubes through the clamping limiting mechanisms arranged in the protection tubes, limiting protection is conducted on the test tubes, and the purposes of sealing and position limiting protection are achieved; by arranging the position adjusting mechanism between the lifting block and the bracket, the test tube can be conveniently inserted into the inner wall of the protection tube, and the placement convenience is improved.

The present invention relates to a blood test method based on electrochemical impedance spectroscopy that can calculate clinical indicators in real time without separate clinical test equipment for calculating clinical indicators by changing the initial values ​​of blood parameters to fit the actual impedance and virtual impedance of the blood, and calculating clinical indicators using the blood parameters with changed initial values.

The utility model relates to blood test technical field discloses a blood internal medicine nursing test equipment, including organism, the top fixedly connected with sound insulation mechanism of organism, the front side inner wall fixedly connected with two test bins of organism, the inside of two test bins is fixedly connected with fixed establishment respectively, the front and back side inner wall fixedly connected with a plurality of baffle no.

This application relates to the field of neurodegenerative diseases and discloses the application of substances that detect the expression of human JUN and / or XCL2 genes in the preparation of products for detecting human Parkinson's disease. This application also discloses a product for detecting human Parkinson's disease, said product comprising substances that detect the expression of human JUN and / or XCL2 genes. The product provided by this application can achieve screening, diagnosis, or prediction of Parkinson's disease through blood tests, overcoming the technical obstacle of existing technologies that rely solely on cerebrospinal fluid diagnosis during the asymptomatic phase. This greatly alleviates patient suffering and promotes the treatment strategy of early detection and early treatment of the disease, and has significant implications for the diagnosis, treatment, and research of Parkinson's disease.

This invention discloses the application of the serum biomarker miR-206 in the preparation of Alzheimer's disease diagnostic products. This invention is the first to use the serum biomarker miR-206 in the effective and auxiliary diagnosis of Alzheimer's disease, demonstrating extremely high diagnostic performance. This invention lays the technical and data foundation for the development of stable and reliable Alzheimer's disease point-of-care testing kits or automated chemiluminescence detection systems and other in vitro diagnostic products. It has significant clinical application prospects in promoting the transformation of early screening and auxiliary diagnosis of Alzheimer's disease from reliance on complex imaging and cerebrospinal fluid examinations to convenient, non-invasive blood tests.

The present invention relates to a method for producing health-functional milk, comprising the step of selecting healthy dairy cows suitable for raw milk production by analyzing their health status after performing a comprehensive health examination including blood tests on dairy cows, and milking the selected dairy cows while feeding them a feed for constitutional improvement according to the lactation period after calving; wherein the comprehensive health examination includes protein metabolism, energy metabolism, liver function, and mineral metabolism. Accordingly, compared to milk produced by conventional methods, it can exhibit effects such as a fresh taste, reduced off-flavors and fishy tastes, and immune activity.

The invention discloses an auxiliary elimination method for abnormal values of diabetes mellitus blood test under a multilayer sensing network, and relates to the technical field of auxiliary elimination of abnormal values of diabetes mellitus blood test. And extracting a diabetes blood test sample set influenced by label definition adjustment according to the label definition contrast structure, and determining a label drift state in the diabetes blood test training data under the condition that the label definition is adjusted by comparing expression differences of the same feature combination under different label definitions. According to the method, the problem of label drift caused by the fact that training data labels are not adjusted along with clinical standards in time is solved, dynamic identification and structured correction of judgment standards in an abnormal value identification strategy in a multi-layer sensing network are achieved, and therefore the accuracy of edge sample judgment and the adaptive capacity of a model to medical standard changes are improved.

1. The name of the design product: blood treatment tray. 2. The use of the design product: for placing blood test tube and other blood treatment supplies. 3. The design points of the design product: the combination of shape and color. 4. The picture or photo that best shows the design points: perspective view. 5. The design claimed contains color.

The invention relates to a transdermal patch combined with an electronic control system in the form of a smartwatch. The patch features a display that shows information about the current status and drug delivery. Simultaneously, electrical contacts within the patch enable the targeted delivery of active ingredients under the skin. The system reacts in real time to the patient's condition and can be used for various applications including insulin control, blood measurement and vacuum blood tests. The invention offers precise and needs-based control of drug delivery and enables continuous monitoring and adjustment based on the patient's current needs.

Some embodiments of a blood coagulation testing system include an analyzer console device and a single-use cartridge component configured to releasably install into the console device. In some embodiments, the blood coagulation testing system can operate as an automated thromboelastometry system that is particularly useful, for example, at a point-of-care site.

1. Name of the product in this design: Blood Cell Detection Reagent Card. 2. Purpose of this design: Blood cell test reagent card, used in conjunction with testing equipment to perform one or more routine blood tests and immune tests, commonly used in emergency rooms, primary healthcare settings and other scenarios. 3. The key design feature of this product is its shape. 4. The image or photograph that best illustrates the design points: 3D view of the combined state 1. 5. Other components requiring explanation: The blood cell test reagent card includes component 1, component 2 and component 3. Component 3 is the reagent card body. Components 1 and 2 are transfusion devices used to deliver the blood sample to be tested into the reagent card body. Components 1 and 2 are detachably plugged into designated parts of component 3. The test can be started after either component 1 or 2 is inserted or both are inserted. Combination state 1 is the state after both component 1 and component 2 are inserted; combination state 2 is the state after component 1 is inserted but component 2 is not inserted; combination state 3 is the state after component 2 is inserted but component 1 is not inserted.

The application discloses a kind of bone defect repair material adaptability prediction methods based on deep learning, the bone defect region and host bone region in three-dimensional CT image data are overlapped and evenly divided, and the three-dimensional visual Transformer model of multi-scale position coding is used to carry out position coding and feature extraction to multiple sub-blocks, to obtain anatomical and functional characteristics;Pathophysiological characteristics are constructed after calculating bone metabolic activity score and systemic inflammation score based on blood test data;Anatomical and functional characteristics, pathophysiological characteristics, parameter data and multi-direction multi-head cross attention layer are interacted in multiple rounds, in each round, select a modal feature as a query vector, select any modal feature in the remaining modal feature as a key vector and a value vector;The interactive features of each round are fused, and the adaptability score and risk level of bone repair material are determined by combining the attention weight in the multi-direction multi-head cross attention layer and the bone metabolic activity score.

1. The name of the design product: blood coagulation instrument. 2. The use of the design product: for blood test in department of hematology. 3. The design points of the design product: in shape. 4. The picture or photo that can best show the design points: perspective view.

Provided herein are computer-implemented methods and systems for predicting the onset or progression of medical conditions using data from electronic health records (EHR) or electronic medical records (EMR), such as time-stamped blood-test values, in combination with trained predictive models. In some aspects, the predictive models comprise statistical or machine-learning algorithms trained using supervised learning on labeled clinical data. The disclosed methods and systems can generate individualized risk scores, classify subjects relative to operating thresholds, and optionally generate or record treatment recommendations in an EHR or EMR. The methods and systems can be applied to human or non-human subjects, enabling early detection of medical conditions, personalized risk assessment, and integration with healthcare information infrastructure.

This invention provides a multimodal signal fusion method for brain-computer interfaces, belonging to the field of data processing technology. Specifically, it includes: acquiring electroencephalogram (EEG) signals, functional magnetic resonance imaging (fMRI) signals, and blood test data; performing time alignment based on a unified time reference; performing modality-specific preprocessing and quality control; constructing a five-level brain topology hierarchy based on brain physiological priors to achieve spatial-physiological alignment of electrode space, brain region space, and biochemical indicators; extracting multi-scale features of each modality based on the five-level brain topology hierarchy; projecting the multi-scale features onto a unified semantic space and achieving semantic alignment through cross-modal comparative learning based on physiological perception; constructing a physiologically guided cross-modal hierarchical fusion network to fuse features of each modality layer by layer from coarse to fine scales, and performing global aggregation based on physiological weights to generate multimodal fusion features. This invention improves fusion efficiency, accuracy, and adaptability.

The application discloses a blood smear white blood cell classification counting method and system based on image analysis, and belongs to the technical field of medical image processing. The method comprises the following steps: after collecting a peripheral blood smear image, performing adaptive background correction and color standardization pretreatment; detecting and segmenting each white blood cell through an instance segmentation network; extracting three-dimensional features of nuclear morphology, cytoplasmic staining and nuclear-cytoplasmic ratio and adaptively fusing; adopting a cascade classifier to perform five-class white blood cell classification and abnormal morphology identification; and counting and labeling suspected abnormal cells for review. The classification coincidence rate of the application reaches more than 95%, can effectively identify abnormal morphologies such as atypical lymphocytes, immature cells and toxic granules, and provides technical support for blood tests at the grassroots level.

Some embodiments of a blood coagulation testing system include an analyzer console device and a single-use cartridge component configured to be releasably mounted into the console device. In some embodiments, the blood coagulation testing system can operate as an automated thromboelastometry system that is particularly useful at point-of-care settings, for example.

An object of a system according to an embodiment is to comprehensively evaluate a health condition of a user and provide appropriate medical support.SOLUTION: A system includes a biological data measurement part, a respiration analysis part, a visual analysis part, an inquiry part, an inspection part, and an overall determination part. The biological data measurement unit measures basic biological data such as heart rate, blood pressure, weight, and body temperature. The respiratory analyzer uses audio analysis to look for respiratory related issues of cough or shortness of breath. The visual analyzer uses machine vision to look for skin tone or eye color, a visual indicator of facial swelling. The inquiry unit performs a simple inquiry to the user. The test unit performs a saliva test or a blood test. The comprehensive determination unit performs comprehensive determination based on the collected data, and issues a prescription as necessary.SELECTED DRAWING: Figure 1

Sarcoidosis is a multisystem disease characterized by granulomatous inflammation in affected organs. The present invention discloses kits and a system for a blood test using mycobacterial catalase-peroxidase that has a high positive predictive value for confirming a diagnosis of sarcoidosis.

Traditionally, the risk or progression of health conditions such as acute kidney injury (AKI) or congenital heart failure (CHF) are evaluated based on blood tests. While being worn by a patient, an interstitial patient monitor having at least one working electrode continuously monitors at least potassium in interstitial fluid of a patient. In this way, the interstitial patient monitor can promote early detection of health conditions such as AKI and CHF without laboratory blood tests.

The application relates to the technical field of medical data processing, and discloses a diabetic nephropathy risk assessment model. The model comprises collecting time-series medical data of a diabetic patient, including blood test values, body measurement data and diagnosis and treatment records. For each time point, feature elements are extracted and a temporary risk assessment value is calculated. A historical medical database is connected, similar patient categories are matched, the temporary risk assessment value is corrected by using the risk history of the similar patient categories, and a unified risk assessment value is obtained. The difference between the temporary risk assessment value and the unified risk assessment value is taken as an accuracy index. In combination with the accuracy index and the time-series change of the features, the future nephropathy risk grade of the patient is predicted. The application calibrates individual assessment by using group historical data, generates an internal accuracy index, and improves the accuracy of risk assessment and the reliability of clinical decision-making.

The invention relates to the field of intelligent medical treatment, and discloses a pathological recognition analysis method and system based on a blood detection sample. The method comprises the following steps: acquiring a blood smear microscopic image and extracting a cell contour; performing texture analysis on the interior of the contour to obtain morphological characteristics; judging a potential abnormal region based on the features; carrying out local enhancement on the abnormal region and extracting subtle difference features; based on the difference features, obtaining quantitative pathological descriptors through a deep learning model; identifying abnormal cells according to a matching result of the descriptors and the feature library; and comprehensively analyzing according to an identification result to obtain pathological quantitative indexes. Through a mode of combining local enhancement, a deep learning model and feature library matching, the problems of low blood smear abnormal cell recognition precision and poor efficiency are solved, and the accuracy and automation level of pathological analysis are improved.

The application relates to the technical field of test tube distribution, and discloses an automatic blood test tube distribution device which comprises a visual image processing control mechanism and a configuration bin, the top side of the configuration bin is fixedly connected with a lens extension bin, an inlet groove is formed in the side of the configuration bin, a sliding guide rail is fixedly connected outside the inlet groove, a tray is slidably connected in the sliding guide rail, and a discharging module, a supporting plate, a gas-driven pushing module, a positioning hole plate and a cloth distribution module are arranged in the configuration bin; the visual acquisition control mode is adopted; the corresponding first and second markers are clearly and simply acquired by using the shielding effect of the test tube storage and the tube groove; the corresponding relationship between the markers and the gas-driven pushing module is utilized; the reciprocating gravity-guided conveying and full-tube distribution mode is adopted; the control process is simplified; the test tubes are pushed into the corresponding tube grooves by the gas-driven pushing module; the functions of full replenishment and local replenishment are realized; and the convenience for doctors to use is improved.

This invention discloses a sorting and placement device for blood test tubes, relating to the field of blood testing technology. It includes a test tube rack base, a column, and a base. The column is fixedly connected to the top corner of the test tube rack base, and the base is slidably connected to the outer wall of the column. Both the test tube rack base and the base have placement holes inside, with transparent test tubes connected inside these holes. A silicone gasket is fixedly connected to the top of the placement hole on the test tube rack base, and support columns are fixedly connected to both sides of the top of the test tube rack base. The blood test tube sorting and placement device disclosed in this invention features a height-adjustable base structure, which can accommodate different operators' handling habits and flexibly adjust the limiting position according to the number of test tubes, improving operational convenience. The snap-fit ​​partition design of the dividers, combined with the test item labels, can clearly distinguish different types of blood samples, avoiding sample confusion.

The utility model provides a portable blood test bench, including: mounting plate, operating floor, locking subassembly and two support pillar, operating floor is provided the top of mounting plate, mounting plate bottom is provided with horizontal receiving groove, two ends of two support pillar are respectively hinged to receiving groove both ends, the bottom of two support pillar is provided with vertical chute, the locking subassembly is provided with the locking subassembly, the mounting plate top is provided with the mounting plate bottom. A telescopic column is arranged in each sliding groove in a sliding mode, a plurality of locking grooves are formed in the side wall of each telescopic column, a locking mechanism used for being matched with the locking grooves to lock the telescopic columns and the supporting columns is arranged on the side wall of each supporting column, and the locking assembly is used for locking the free ends of the two supporting columns. The problem that in the prior art, an existing detection table is inconvenient to store is solved.